News and Announcements
Global Healthcare Macro Trends
- Published March 28, 2023 5:39AM UTC
- Publisher Jade Miguel
- Categories Capital Insights
The healthcare sector has been significantly impacted by the pandemic, with hospitals and healthcare professionals facing unprecedented challenges. However, this situation has also accelerated the sector’s growth and innovation.
In this video, Joseph Mocanu, Managing Partner at Verge HealthTech Fund, shares his insights on global healthcare macro trends and opportunities for both founders and investors.
Learn about the latest developments in the healthcare industry and how to stay ahead of the curve.
#healthcare #healthtech #investors #trends #investment
Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Backed By Leading Investment Groups and Family Offices
